PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brazjmicroLink to Publisher's site
 
Braz J Microbiol. 2011 Oct-Dec; 42(4): 1300–1307.
Published online 2011 December 1. doi:  10.1590/S1517-83822011000400009
PMCID: PMC3768752

Vulvovaginal candidiasis in Mato Grosso, Brazil: pregnancy status, causative species and drugs tests

Abstract

Causative agent in majority of VVC is Candida albicans, but infection due to non-C. albicans is common. Use of empiric antifungal therapy in Brazil due to syndromic management of vulvovaginitis could act as risk factor for increase resistance among VVC causative agents. From Mato Grosso patients, 160 with culture-proved among 404 women who had clinical symptoms of VVC, were enrolled in this study. 70 non-pregnant women and 90 pregnant women were included. Candida albicans was the most prevalent, representing 72.9% in the non-pregnant group and 92.3% in the pregnant group. Differences in species distribution were noted between the two groups, being C. parapsilosis the second more prevalent species among non-pregnant women. Susceptibility testing revealed high susceptibility to fluconazole (except for C. krusei), itraconazole, ketoconazole, and amphotericin B regardless the species (C. albicans, C. parapsilosis, C. tropicalis, C. glabrata, C. krusei) analyzed.

Keywords: Vulvovaginal candidiasis, antifungal susceptibility testing, antifungal agents, Candida albicans

Articles from Brazilian Journal of Microbiology are provided here courtesy of Elsevier